Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary E Landreth

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Immunometabolism (Cobham, Surrey)|November 7, 2022
The intersection of metabolism and inflammation is governed by the intracellular topology of hexokinases and the metabolic fate of glucoseJuan F Codocedo, Gary E Landreth
Bio-Protocol|May 19, 2017
Aβ Extraction from Murine Brain HomogenatesBrad T Casali, Gary E Landreth
Expert Opinion on Therapeutic Targets|July 2, 2011
Nuclear receptors as therapeutic targets for Alzheimer's diseaseShweta Mandrekar-Colucci, Gary E Landreth
Journal of Neuroinflammation|November 11, 2006
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's diseaseBrandy L Wilkinson, Gary E Landreth
CNS & Neurological Disorders Drug Targets|March 9, 2010
Microglia and inflammation in Alzheimer's diseaseShweta Mandrekar-Colucci, Gary E Landreth
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2010
The role of microglia in amyloid clearance from the AD brainC Y Daniel Lee, Gary E Landreth
Progress in Brain Research|November 19, 2018
ERK/MAPK signaling and autism spectrum disordersJoseph Vithayathil, Joanna Pucilowska, Gary E Landreth
Current Topics in Microbiology and Immunology|August 19, 2009
Toll-like receptors in Alzheimer's diseaseGary E Landreth, Erin G Reed-Geaghan
CNS Drugs|December 13, 2007
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implicationsQingguang Jiang, Michael Heneka, Gary E Landreth
Nature Clinical Practice. Neurology|September 7, 2007
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disordersMichael T Heneka, Gary E Landreth, Michael Hüll
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Immunometabolism (Cobham, Surrey)|November 7, 2022
The intersection of metabolism and inflammation is governed by the intracellular topology of hexokinases and the metabolic fate of glucoseJuan F Codocedo, Gary E Landreth
Bio-Protocol|May 19, 2017
Aβ Extraction from Murine Brain HomogenatesBrad T Casali, Gary E Landreth
Expert Opinion on Therapeutic Targets|July 2, 2011
Nuclear receptors as therapeutic targets for Alzheimer's diseaseShweta Mandrekar-Colucci, Gary E Landreth
Journal of Neuroinflammation|November 11, 2006
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's diseaseBrandy L Wilkinson, Gary E Landreth
CNS & Neurological Disorders Drug Targets|March 9, 2010
Microglia and inflammation in Alzheimer's diseaseShweta Mandrekar-Colucci, Gary E Landreth
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2010
The role of microglia in amyloid clearance from the AD brainC Y Daniel Lee, Gary E Landreth
Progress in Brain Research|November 19, 2018
ERK/MAPK signaling and autism spectrum disordersJoseph Vithayathil, Joanna Pucilowska, Gary E Landreth
Current Topics in Microbiology and Immunology|August 19, 2009
Toll-like receptors in Alzheimer's diseaseGary E Landreth, Erin G Reed-Geaghan
CNS Drugs|December 13, 2007
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implicationsQingguang Jiang, Michael Heneka, Gary E Landreth
Nature Clinical Practice. Neurology|September 7, 2007
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disordersMichael T Heneka, Gary E Landreth, Michael Hüll
Pageof 12